Combat chronic lung disease at COPD Day 2010
COPD, or chronic obstructive
pulmonary disease, is a leading cause of death in the Tri-State.
is a serious lung ailment that blocks your airways, making it hard to get air
in and out.
by damage to the lungs over many years, COPD usually results from long-term smoking. Emphysema and chronic bronchitis are the two main conditions that make
up the disease. While irreversible,
treatments and lifestyle changes can help you feel better, stay more active and
slow the progress of COPD.
The Kentucky Heart Foundation Inc. and King’s Daughters Center for Pulmonary
Health as nurse practitioner Anna Bayes and a panel of experts discuss how to
breathe better and live comfortably with COPD.
educational session takes place from 1 to 4 p.m. Wednesday, Nov. 17, at the KDMC Health Education Center in the lower level of the
Lexington Avenue parking garage, 2201 Lexington Ave., Ashland.
“While more than 12 million people are
currently diagnosed with COPD in the United States, many more may have the
disease and not know it,” added Anna Bayes, nurse practitioner. “That’s why
COPD Day is such an important event for our region. It allows us to help those
living with the disease, and assess those who might be at risk for it.”
COPD Day will feature the following:
how to combat COPD symptoms before they become worse is the key. This event is
designed to give you all of the necessary information you need to take control
of the disease and get your life back,” added Bayes.
event is open to anyone, although reservations are requested. Reserve your seat
by calling 1-888-377-KDMC (5362). Refreshments will be provided. Convenient parking
is available in the lot at the corner of Lexington Avenue and 22nd Street, next to the KDMC Human Resources building.
The Kentucky Heart
Foundation is a non-profit organization dedicated to improving the quality of
life in the Tri-State and Appalachian region; reducing the devastating impact
of cardiovascular disease; advancing medical science through integrated,
innovative and progressive programs in research, education, prevention, early
detection and improved patient care; creating access to cutting-edge technology
and the latest knowledge about cardiovascular disease; and developing a forum
for research that will benefit patients throughout the nation.
This activity is supported through an independent educational grant from
Pfizer to the Physicians’ Institute of Excellence in Medicine as part of the
ACES Collaborative for the improvement and management of COPD. The Physicians’
Institute retains full control over the distribution of individual grants under
Notify me of followup comments via e-mail